baber/WOPTO huggingface dataset:
Patent IL-113688-A0 (IL)
Title: Perfluoroalkyl-substituted benzoylguanidines, a process for their preparation their use as a medicament or diagnostic agent and a medicament containing them
IPC: C07D207/09
Filed: 1995-05-11
Abstract: Perfluoro alkyl-substd. benzoyl guanidine derivs. of formula (I) and their salts are new. R1 = SOmR6; m = 0-2; R6 = 1-6C perfluoroalkyl; R2, R3 = H, F, Cl, Br, I, 1-4C alkyl, 1-4C alkoxy, phenoxy (opt. mono-, di- or tri-substd. with F, Cl, Me or OMe); R4, R5 = H, 1-3C alkyl, F, Cl, Br, I, CN, OR7, NR8R9, (CH2)n-(CF2)p-CF3; R7- R9 = H or 1-4C alkyl; n = 0-1; p = 1-2.
Patent IL-117216-A0 (IL)
Title: Surface-modified filler composition
IPC: C08K9/04
Filed: 1996-02-21
Abstract: PCT No. PCT/EP96/00743 Sec. 371 Date Aug. 25, 1997 Sec. 102(e) Date Aug. 25, 1997 PCT Filed Feb. 22, 1996 PCT Pub. No. WO96/26240 PCT Pub. Date Aug. 29, 1996A filler composition for thermoplastic olefins or thermoplastic elastomers which comprises a halogen-free, flame-inhibiting filler which has been surface-treated with fatty acid derivatives and optionally a siloxane derivative.
Patent IL-120780-A0 (IL)
Title: Drying apparatus with rotatable housing
IPC: D06F/
Filed: 1996-10-21
Abstract: A thermal vaporization apparatus includes a cylindrical tube having two ends. A base is provided, with the tube being rotatable with respect to the base. A first drive mechanism applies rotating force to the tube. An auger having two ends extends through the tube, and a second drive mechanism applies rotating force to the auger. At least one gas-fired burner to heat the exterior of the tube while in rotation is provided. A feed mechanism for introducing wet material into the interior of the tube and exterior of the auger within the tube is also provided.
Patent IL-124991-A0 (IL)
Title: A multifocal lens combining the advantages of progressive addition lenses and diffractive lenses
IPC: G02B3/10
Filed: 1998-06-18
Abstract: A multifocal lens (22) having far and near vision zones is presented. The lens comprises a substrate (24) in the form of a progressive addition lens and a modulation (26) formed on a surface (24A) of the substrate. The substrate lens has far and near vision zones (28 and 30), selected in accordance with respective prescribed values of optical power required for the patient's eye at his distance and reading vision, and an intermediate transition region (32) between the far and near vision zones. The modulation is of kind producing locally variable power addition such that the far and near vision zones of the multifocal lens (22) are wider than the far and near vision zones (28 and 30) of the substrate (24). <IMAGE>
Patent IL-128289-A0 (IL)
Title: Compression or expansion device
IPC: F04B35/00
Filed: 1999-01-29
Abstract: A compressor or expansion device (1) for use with compressive fluid and comprising a flexible hose (8) connected between a pair of ports (5A, 5B) and against which a pair of spaced apart, adjacent contact elements bear whereby a portion of the hose is substantially occluded at both ends entrapping a quantity of compressive fluid therewithin. The pair of spaced apart, adjacent contact elements are displaced along the hose from an inlet port (5A) of the pair of ports to an outlet port (5B) thereof so as to provide a flow of compressive fluid therebetween. The hose tapers between the pair of ports such that the quantity of compressive fluid is respectively entrapped in a first volume V1 proximal the inlet port and a second volume V2 proximal the outlet port whereby a ratio of pressures P1/P2 at the pair of ports is proportional to a ratio of the volumes V2/V1 in accordance with general equation (I), where k is the adiabatic power for the compressive fluid.
Patent IL-136102-A0 (IL)
Title: Initiation of an analytical measurement
IPC: G01N33/558
Filed: 2000-05-12
Abstract: A distinctive optical signature permits a fluidic medical diagnostic device to measure an analyte concentration or a property of whole blood, particularly the coagulation time, only after first insuring that a whole blood sample has been introduced into the device. A suitable device has at one end a sample port for introducing a sample and at the other end a bladder for drawing the sample to a measurement area. By requiring a meter, used in conjunction with the device, to first detect the distinctive optical signature, a sample is drawn to the measurement area only if it is whole blood. In that case, a channel carries the sample from the sample port to the measurement area, and a stop junction, between the measurement area and bladder, halts the sample flow. The meter measures a physical property of the blood sample - typically, optical transmittance - after it has interacted with a reagent in the measurement area. <IMAGE>
Patent IL-140553-A0 (IL)
Title: Formaldehyde dehydrogenase genes from methylotrophic yeasts
IPC: C12N15/53
Filed: 1999-07-02
Abstract: The present invention provides formaldehyde dehydrogenase genes (FLD) from methylotrophic yeasts. The FLD structural genes confer resistance to formaldehyde and are therefore useful as a selectable marker in methylotrophic yeasts. The FLD promoter sequences are strongly and independently induced by either methanol as sole carbon source (with ammonium sulfate as nitrogen source) or methylamine as sole nitrogen source (with glucose as carbon source). Induction under either methanol, methylamine or both provides levels of heterologous gene expression comparable to those obtained with the commonly used alcohol oxidase I gene promoter (P?AOX1?). The FLD promoter of Pichia pastoris (P?FLD1?) is an attractive alternative to P?AOX1? for expression of foreign genes in P. pastoris, allowing regulation by carbon (methanol) or nitrogen (methylamine) source within the same expression strain. Yeast strains, expression cassettes, expression vectors, and host cells comprising an FLD gene promoter and 3' termination sequence are also provided.
Patent IL-144124-A0 (IL)
Title: Device for dosing administering an injectable product
IPC: A61M5/315
Filed: 2000-01-11
Abstract: The invention refers to a device for administering an injectable product in doses, comprising a casing, itself comprising: a reservoir for the product; a piston which forces product out of the reservoir when moved in a feed direction towards a reservoir outlet; a drive member; a driven member which is slaved by the drive member when the drive member is moved in the feed direction, so moving the piston in the feed direction; and a dosing member which may be rotated about the sliding axis of the drive member, to set the product dosage to be administered. The drive member and the dosing member abut each other via at least one dosage stopper each, one of which is provided on the drive member and the other on the dosing member. At least one of these dosage stoppers at least partially encircles the sliding axis of the drive member in the form of a spiral. The at least one spiral dosage stopper exhibits a continuous course with a constant pitch alpha.
Patent IL-150288-A0 (IL)
Title: Stent-graft with helically arranged securement member
IPC: A61L27/00
Filed: 2001-01-12
Abstract: An improved endoluminal prosthesis is described which possesses increased flexibility and longitudinal compliance with a stent/graft/stent securement member combination.
Patent IL-153676-A0 (IL)
Title: Liposomal pharmaceutical compositions
IPC: A61P35/00
Filed: 2001-06-29
Abstract: This invention relates to improved liposomal camptothecin compositions and methods of manufacturing and using such compositions for treating neoplasia and for inhibiting angiogenesis.
Patent IL-155160-A0 (IL)
Title: Aminopyridinyl-, aminoguanidinyl-and alkoxyguanidinyl- substituted phenyl acetamide derivatives and pharmaceutical compositions containing the same
IPC: A61P29/00
Filed: 2001-10-05
Abstract: Phenyl acetamide compounds are described, including compounds of or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R<SUP>3</SUP>-R<SUP>6</SUP>, R<SUP>11</SUP>, B, Y and W are set forth in the specification. The compounds of the invention are potent inhibitors of proteases, especially trypsin-like serine proteases, such as thrombin and factor Xa. Compositions for inhibiting loss of blood platelets, inhibiting formation of blood platelet aggregates, inhibiting formation of fibrin, inhibiting thrombus formation, and inhibiting embolus formation are described. Other uses of compounds of the invention are as anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage, such as catheters, blood dialysis machines, blood collection syringes and tubes, blood lines and stents. Additionally, the compounds can be detectably labeled and employed for in vivo imaging of thrombi.
Patent IL-158696-A0 (IL)
Title: Method and system for transforming legacy software applications into modern object-oriented systems
IPC: G06F9/44
Filed: 2002-05-10
Abstract: A system and method for transforming a procedural program having procedural language code into an object-oriented program, comprises scanning the procedural language code and creating a map based on the scanned procedural language code, storing the scanned procedural language code as intermediate code, processing at least a segment of the procedural language code using the map, creating a first data structure using the processed segment, modifying the intermediate code based on the first data structure and generating an object-oriented program having an object class based on the modified intermediate code.
Patent IL-160689-A0 (IL)
Title: Benzothiazepine derivatives for treatment of hyperlipidemia
IPC: A61K45/00
Filed: 2002-09-05
Abstract: The present invention relates to compounds of formula (I): wherein variable groups are as defined within; pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidemia. Processes for their manufacture and pharmaceutical compositions containing them are also described
Patent IL-161150-A0 (IL)
Title: Passive opto-electronic monitoring device
IPC: G02B17/08
Filed: 2002-10-01
Abstract: The present invention relates to an optronic passive surveillance device, especially for infrared surveillance. It comprises a front optic ( 1 ) of given useful instantaneous field, means ( 2 ) for scanning a scene with a given total field of observation, means ( 3 ) for forming the image of the scene and means ( 4 ) for detecting said image. According to the invention, the detection means ( 4 ) comprise a two-dimensional matrix detector ( 41 ), the field of the detector along each of the dimensions being greater than or equal to said useful instantaneous field of the front optic along said dimension, and allow the acquisition, for each elementary area of the scene corresponding to the useful instantaneous field of the front optic, of N subimages formed on said detector (N>=1), with a given integration time for each subimage. The device furthermore includes counterscanning means ( 6 ) making it possible to compensate for the movements of the image that are due to the scanning of the scene during the acquisition of the N subimages.
Patent IL-173376-A0 (IL)
Title: Dual universal integrated circuit card
Filed: 2006-01-26
Abstract: The present invention discloses the dual universal integrated circuit card(UICC) system for a portable device, the portable device includes a cellular phone or a personal digital assistance. The system comprises a slaver integrated circuit(IC) card having a first integrated circuit(IC). A substrate is carrying for a master integrated circuit(IC) card having a second integrated circuit(IC) and a contact interface. The contact interface is coupled to the first and second integrated circuit(IC). An antenna may be coupled to the second integrated circuit(IC) for transmitting information.
Patent IL-175675-A0 (IL)
Title: Tricyclic 1-[(3-indol-3-yl)carbonyl] piperazine derivatives as cannabinoid cb1 receptor agonists
IPC: C07D471/06
Filed: 2006-05-16
Abstract: The invention relates to tricyclic 1-[(indol-3-yl)carbonyl]piperazine derivative having the general Formula (I) wherein X is CH2, O or S; R represents 1-3 substituents independently selected from H, (C1-4)alkyl, (C1-4)alkyloxy and halogen; R1 is (C5-8)cycloalkyl; R2 is H or (C1-4)alkyl; R3, R3′, R4′ R4′, R5, R5′ and R6′ are independently hydrogen or (C1-4)-alkyl, optionally substituted with (C1-4)alkyloxy, OH or halogen; R6 is hydrogen or (C1-4)alkyl, optionally substituted with (C1-4)alkyloxy, OH or halogen; or R6 forms together with R7 a 4-7 membered saturated heterocyclic ring, optionally containing a further heteroatom selected from O and S; R7 forms together with R6 a 4-7 membered saturated heterocyclic ring, optionally containing a further heteroatom selected from O and S; or R7 is H, (C1-4)alkyl or (C3-5)cycloalkyl, the alkyl groups being optionally substituted with OH, halogen or (C1-4)alkyloxy; or a pharmaceutically acceptable salt thereof. The invention also relates to pharmaceutical compositions comprising said tricyclic 1-[(indol-3-yl)carbonyl]piperazine derivatives, and to the use of these derivatives in the treatment of pain, such as peri-operative pain, chronic pain neuropathic pain, cancer pain, and pain and spasticity associated with multiple sclerosis.
Patent IL-178271-A0 (IL)
Title: Flicker-type flying toy device
IPC: A63H33/18
Filed: 2006-09-25
Abstract: A flying toy (10) includes a planar body defining an outer edge (16). A recess (18) extends inwardly from die outer edge and includes an undercut section (22). The body defines a hook section (24) adjacent the undercut section of the recess, and a finger engagement section (28) opposite the hook section that defines a pair of wings (32, 34). The wings are resilient, and include outer end areas that can be spread apart. The recess is configured to receive the tip of a user's finger. When the user's fingertip is positioned within the recess, the hook section engages one side of the user's finger and the finger engagement section engages an opposite side of the user's finger. The wings spread apart so as to stabilize the body on the user's finger. The user flicks his or her finger to dislodges the flying toy from the user's fingertip, and the flying toy is then propelled through the air.
Patent IL-190802-A0 (IL)
Title: Therapeutic combination of amlodipine and benazepril/benazeprilat
IPC: A61P11/00
Filed: 2008-04-10
Abstract: The present invention especially relates to the use of a combination comprising  (1) an ACEI selected from the group consisting of benazepril, benazeprilat, and pharmaceutically acceptable salts thereof, and  (2) amlodipine or pharmaceutically acceptable salt thereof,  
for the manufacture a medicament for the treatment or prevention or delay of progression of a condition selected from the group consisting of hypertension, congestive heart failure, angina, myocardial infarction, artherosclerosis, diabetic nephropathy, diabetic cardiac myopathy, renal insufficiency, peripheral vascular disease, left ventricular hypertrophy, cognitive dysfunction, blood pressure-related cerebrovasular disease, stroke, pulmonary disease or pulmonary hypertension and headache; 
wherein  (i) the amount of amlodipine or a pharmaceutically acceptable salt thereof corresponds to 6 mg to 40 mg of the free base and  (ii) the amount of the ACE inhibitor or a pharmaceutically thereof corresponds to 20 mg to 160 mg of benazepril hydrochloride.
Patent RO-127029-A0 (RO)
Title: Dct ()
Inventor: HANTULIE OANA NICOLETA
IPC: E03D1/02
Filed: 2011-08-23
Abstract: The invention relates to a toilet cleaning device mounted in connection with a toilet bowl, which permits a solution which concomitantly ensures washing, disinfection and perfuming, to come into contact with the said toilet bowl at the same time with the flush water. According to the invention, the device consists of a vessel () placed within a toilet water tank, fixed to a tank lid () by means of a plastic plug (), between the plug () and the lid () there being placed a gasket (), while inside the tank there is placed a float () at the upper part of which there is fixed, by means of a bronze nut (), a lower screw () of a central mobile axle (), at the lower part of the vessel () there being screwed a lower plug () confining a dosing chamber (), some sealing gaskets () being mounted between an inner collar of the vessel () and an outer collar of the central mobile axle (), as well as between said outer collar and the lower plug ().
Patent RO-130772-A0 (RO)
Title: Process for stopping accidental fraying in protective knitted nets
Inventor: APARASCHIVEI SABIN
IPC: D02J3/18
Filed: 2015-02-19
Abstract: The invention relates to a process for stopping accidental fraying in protective knitted nets used in sports fields. According to the invention, the process consists in submerging the textile protective nets into an aqueous dispersion of natural or synthetic polymers, removing the excess by centrifugation and water evaporation, to result in the consolidation of weft threads with the warp threads.
Patent RO-132809-A0 (RO)
Title: Equipment for carrying a bicycle on a person's shoulder
Inventor: LOGHIN SORINEL
IPC: B62J99/00
Filed: 2018-05-22
Abstract: The invention relates to an equipment for carrying a bicycle on a person's shoulder. According to the invention, the equipment consists of a support (2) made of a rigid material, having one or several protuberances (3) that prevents the bicycle from slipping away from the person's shoulder, the support (2) being fixed by means of a fastening system (4) made of belts or straps provided with buckles, for adjusting their length.
Patent AP-2000001996-A0 (AP)
Title: Heterocyclic inhibitors of P38.
Inventor: SALITURO FRANCESCO GERALD
IPC: A61P35/00
Filed: 1999-05-11
Abstract: The present invention relates to inhibitors of p38, a mammlian protein kinase involved in cell proliferation, cell death and response to extracellular stimuli. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.
Patent MC-2279-A1 (MC)
Inventor: PETER DAVID DAVIS
IPC: C07D487/02
Filed: 1991-07-30
Abstract: Compounds of the formula <CHEM> wherein R<1> and R<3> together form a bond and R<2> represents hydrogen or R<1> and R<2> together form a bond and R<3> represents hydrogen; R<4>, R<5>, R<6> and R<7> each independently represent hydrogen, halogen, alkyl, haloalkyl, alkoxy, nitro, amino, alkanoylamino, aroylamino, alkylthio or alkylsulphonyl; R<8> represents hydrogen, alkyl or aralkyl; X represents -N(R<9>)- or -CHN(R<1><0>,R<1><1>)- in which R<9>, R<1><0> and R<1><1> each represent hydrogen, alkyl, aralkyl or alkanoyl; m stands for 0-2 and n stands for 1-3, with the proviso that the sum of m and n is 1-3; p stands fo 0-4 and q stands for 0-4, with the proviso that the sum of p and q is 2-4 when X represents -N(R<9>)-, that the sum of p and q is 1-5 when X represents -CHN(R<1><0>,R<1><1>)- and R<1> and R<2> together form a bond, that the sum of p and q is 0-4 when X represents -CHN(R<1><0>,R<1><1>)- and R<1> and R<3> together form a bond and that p stands for 1-4 when X represents -N(R<9>)-, R<1> and R<3> together represent a bond and m stands for 0, as well as pharmaceutically acceptable salts of acidic compounds of formula I with bases and of basic compounds of formula I with acids, are useful in the control or prevention of inflammatory, immunological, oncological, bronchopulmonary, dermatological or cardiovascular disorders or for the treatment of asthma, AIDS or diabetic complications or for the stimulation of hair growth. They can be prepared from correspondingly substituted furandiones.
Patent IE-910168-A1 (IE)
Title: Footwear
IPC: A43B9/10
Filed: 1991-01-18
Abstract: In making a boot or shoe of the veldtschoen type, the upper (10) is lasted to a runner (14) and has its bottom edge turned outward to form a flange (12) which is stitched to the runner, the part of the runner outward of the stitching being cut away. A sole unit (18) is moulded directly on to the runner and the underside of an edge portion of the flange (12) projecting beyond the runner.
Patent IE-910985-A1 (IE)
Title: Sterile or specific pathogen free environment products
IPC: C12M/
Filed: 1991-03-25
Abstract: Methods of maintaining or providing sterile or specific pathogen free environments are disclosed. The methods involve the use of semi-permeable membrane materials between the sterile or pathogen free environment and surrounding potentially hostile environments. One particular method and apparatus is described for introducing drugs or other secondary substances to a sterile liquid for example for transfusion to a patient. The apparatus has a first port (4) for connection to a container of sterile solution second port (5) for connection to a transfer tuber and a third port (9) for introduction of the secondary substance. The connection between the third port and the other ports is by way of a semi-permeable membrane (11) selected to permit the passage of the secondary substance while preventing the ingress of pathogens or other potentially harmful organisms. <IMAGE>
Patent MA-21481-A1 (MA)
Inventor: PATRICK COLUMNKILL MC CALL
IPC: A61K8/23
Filed: 1989-01-24
Abstract: Disclosed are selenium sulfide lotion shampoos containing a mixture of xanthan gum and magnesium aluminum silicate as a suspending system.
Patent MA-24040-A1 (MA)
Inventor: SCOTT LEE WELLINGTON
IPC: A47G25/90
Filed: 1996-12-25
Abstract: A combustor method and apparatus is provided. The method utilizes flameless combustion with one or more of three improvements to enhance ignition of the flameless combustor. A catalytic surface can be provided within a combustion chamber to provide flameless combustion at least in the vicinity of the catalytic surface at a temperature that is much lower than the autoignition temperature of fuel in air without the presence of the catalytic surface. Nitrous oxide or supplemental oxygen may also be used as an oxidant either instead of air or with air to reduce ignition temperatures. Further, electrical energy can be passed through the fuel conduit, raising the temperature of the conduit to a temperature above which the fuel will ignite when combined with the oxidant.
Patent MA-25511-A1 (MA)
Inventor: CHRYSTELLE LANGLAIS
IPC: C02F1/52
Filed: 2002-06-04
Abstract: A method for membrane filtration of effluent water containing suspended matter reduces membrane clogging and improves filtration capacity of the membrane. The method includes adding a dose of a preselected coagulation reactant to the effluent before the effluent passes over the membrane. The added dose is a fraction of the coagulating reactant dose (X) that would render the zeta potential of the effluent equal to zero. The range of the added dose is X/30-X/80. The suspended matter in the effluent is subjected to the added dose of coagulation reactant for destabilizing the suspended matter.
Patent MA-42878-A1 (MA)
Title: Système, dispositif intelligent et procédé de répartition des opérations et des coûts d'un dispositif intelligent.
Inventor: DAMSTRA THOM
IPC: H04W4/12
Filed: 2016-01-14
Abstract: L'invention concerne un système, un dispositif intelligent et un procédé de répartition des coûts des opérations d'un dispositif intelligent entre différentes tâches. Des informations d'opérations concernant des opérations effectuées par le dispositif intelligent sont enregistrées. Les opérations sont distribuées entre tâches en fonction d'informations de catégorisation et des informations d'opérations. Le coût des opérations réparties effectuées par le dispositif est déterminé pour les tâches en fonction des informations d'opérations et d'informations tarifaires.